Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

6.61p
   
  • Change Today:
      0.25p
  • 52 Week High: 17.60p
  • 52 Week Low: 1.50p
  • Currency: UK Pounds
  • Shares Issued: 502.72m
  • Volume: 2,343,292
  • Market Cap: £33.23m
  • RiskGrade: 328
  • Beta: 1.22

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £98,387
Lisa Baderoon 583,963 £38,600
Tim Franklin 525,000 £34,702

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 25,108,044 £1,659,642
Invesco Ltd 17,872,341 £1,181,362
Aviva Investors Global 11,285,180 £745,950
Alora Pharmaceuticals LLC 10,909,091 £721,091
M&G Investments 7,600,000 £502,360
Prudential plc 7,600,000 £502,360
Capital Income Builder 4,870,367 £321,931
Dr R Zimmer 4,551,553 £300,858
Odey Asset Management 3,433,319 £226,942
Rhone Trustees (Switzerland) SA 3,386,000 £223,815
Pictet Overseas Trust Corporation Limited 3,287,500 £217,304

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 6.61p
Change Today 0.25p
% Change 3.93 %
52 Week High 17.60p
52 Week Low 1.50p
Volume 2,343,292
Shares Issued 502.72m
Market Cap £33.23m
Beta 1.22
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average
Price Trend
67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 02-Feb-2026

Time Volume / Share Price
15:44 225,742 @ 6.75p
16:29 1,484 @ 6.90p
16:09 8,596 @ 6.45p
16:08 320 @ 6.90p
15:49 9,200 @ 6.75p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page